TesoRx Pharma, LLC Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
TesoRx is a privately held pharmaceutical company developing a first-in-class unmodified oral testosterone for androgen deficiency. It is in the process of completing a phase two clinical study and is on track to commence dosing for phase three by early 2026.